Reviewed by Michael Gill, B. Sc.
2 Ankylosing Spondylitis Clinical Trials Near Me
Top Hospitals for Ankylosing Spondylitis Clinical Trials
Image of West Tennessee Research Institute in Tennessee.
West Tennessee Research Institute
Jackson
1Active Trials
2All Time Trials for Ankylosing Spondylitis
2016First Ankylosing Spondylitis Trial
Image of Precision Comprehensive Clinical Research Solutions in Texas.
Precision Comprehensive Clinical Research Solutions
Colleyville
1Active Trials
2All Time Trials for Ankylosing Spondylitis
2018First Ankylosing Spondylitis Trial
Top Cities for Ankylosing Spondylitis Clinical Trials
Image of Duncansville in Pennsylvania.
Duncansville
3Active Trials
Altoona Center for Clinical ResearchTop Active Site
Image of Phoenix in Arizona.
Phoenix
2Active Trials
Arizona Arthritis & Rheumatology Research, PLLC - PhoenixTop Active Site
Ankylosing Spondylitis Clinical Trials by Phase of Trial
Phase 2 Ankylosing Spondylitis Clinical Trials
1Active Ankylosing Spondylitis Clinical Trials
1Number of Unique Treatments
21Number of Active Locations
Ankylosing Spondylitis Clinical Trials by Age Group
18+ Ankylosing Spondylitis Clinical Trials
2Active Ankylosing Spondylitis Clinical Trials
Most Recent Ankylosing Spondylitis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Ankylosing Spondylitis Clinical Trials
Treatment Name
Active Ankylosing Spondylitis Clinical Trials
All Time Trials for Ankylosing Spondylitis
First Recorded Ankylosing Spondylitis Trial
CC-99677
1
1
2021
Bimekizumab
1
5
2016
Recently Completed Studies with FDA Approved Treatments for Ankylosing Spondylitis
Treatment
Year
Sponsor
Bimekizumab
2019
UCB Biopharma SRL
Secukinumab
2017
Novartis Pharmaceuticals
Bimekizumab
2017
UCB Biopharma SRL
Upadacitinib
2017
AbbVie

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 6th, 2021

Last Reviewed: October 19th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.